Abstract
Stress can cause or exacerbate psychiatric illness, and effects on the transcription factor CREB within the nucleus accumbens (NAc) are critically involved. In rodents, stress-induced activation of NAc CREB produces elevations in dynorphin (DYN), an endogenous opioid expressed in dopamine D1-receptor (D1R)-expressing medium spiny neurons (MSNs). In turn, elevated DYN signaling produces features of mood and anxiety disorders via actions at kappa-opioid receptors (KORs). Although individual differences in stress sensitivity have been described—with some appearing susceptible and others resilient—the contribution of NAc DYN to these phenotypes is unclear. Here we examined relationships between social behavior and DYN in D1R-expressing MSNs in mice exposed to chronic social defeat stress (CSDS). We used quantitative (q)RNAscope to assess co-expression of genes encoding CREB (Creb1), D1Rs (Drd1), and DYN (Pdyn) within the NAc. To leverage individual variability, we performed regression analyses across all mice, revealing negative correlations between social interaction behavior and expression of Drd1 and Pdyn, linking higher social avoidance with higher expression of these genes. There was no correlation with Creb1, suggesting stress-induced elevations in Pdyn depend on CREB activation (phosphorylation). These findings suggest that stress-related induction of DYN in D1R-expressing MSNs within the NAc is a biomarker of susceptibility.
Keywords: Stress, Nucleus accumbens, Social avoidance, CREB, Dopamine, Dynorphin
Introduction
Stress is implicated in the etiology of mood and anxiety disorders including major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) (Nestler and Carlezon, 2006, Ressler et al., 2022). These conditions share many core features, including diminished ability to experience pleasure or positive emotions (anhedonia), social avoidance, and sleep disruption (American Psychiatric Association, 2013), suggesting a shared pathophysiology. The overlap in symptomatology illustrates potential benefits of using Research Domain Criteria (RDoC) principles (Cuthbert and Insel, 2013) to focus research on translationally-relevant features (e.g., social avoidance) that cut across multiple conditions rather than on narrow diagnostic categories that even highly skilled clinicians may struggle to differentiate in humans (Gros et al., 2012, Ressler et al., 2022). These symptoms are persistent, debilitating, and resistant to treatment, contributing to profound economic and social burdens (Greenberg et al., 1999, Birnbaum et al., 2010).
Stress can produce neuroadaptive responses (alterations in gene and protein expression) that contribute to persistent and often maladaptive changes in behavior (Nestler and Carlezon, 2006, Ressler et al., 2022). While these neuroadaptations occur throughout the brain, work focusing on the nucleus accumbens (NAc) provides strong evidence that stress produces changes in behavior via effects on CREB (cAMP response element binding protein) (Pliakas et al., 2001, Muschamp et al., 2011, Muschamp and Carlezon, 2013, Carlezon and Krystal, 2016), a transcription factor that regulates expression of myriad genes (Carlezon et al. 2005). A variety of stressors (forced swimming, footshock, social defeat) activate CREB in the NAc, which elevates expression of the opioid peptide dynorphin (DYN), which in turn causes depressive behaviors via activation of kappa-opioid receptors (KORs) (Muschamp and Carlezon, 2013, Carlezon and Krystal, 2016). A key mechanism of this effect is that increased DYN acts upon KORs expressed on the terminals and cell bodies of ventral tegmental area (VTA) dopamine (DA) neurons (Svingos et al., 1999, Svingos et al., 2001), producing inhibition of mesolimbic system function. The ability of KOR antagonists to relieve this inhibitory tone is a putative neural mechanism of their antidepressant- and anxiolytic-like effects (Carroll and Carlezon, 2013, Carlezon and Krystal, 2016). Increased CREB and KOR function are implicated in despair/learned helplessness (Pliakas et al., 2001), anxiety/avoidance behavior (Knoll et al., 2007), disrupted attention (Nemeth et al., 2010), anhedonia and fear (Muschamp et al., 2011), and sleep dysregulation (Wells et al., 2017, McCullough et al., 2021). Collectively, these studies suggest that a common pathophysiology within the NAc explains a broad assortment of features that are frequently co-morbid in stress-related disorders. An improved understanding of mechanism may enable development of new treatments that, by targeting the NAc and its specific cell populations, could dramatically improve outcomes by relieving numerous signs of stress-related illnesses simultaneously.
The NAc is the ventral aspect of the striatum, which is composed largely of MSNs that segregate into two major populations, defined by expression of DA D1 or D2 receptors (D1Rs and D2Rs, respectively) (Gerfen et al., 1990). Considerable evidence indicates that DYN in the NAc arises primarily from D1R-expressing MSNs. Specifically, seminal in situ hybridization studies showed that prodynorphin (Pdyn)—the gene encoding DYN—segregates with D1R–expressing MSNs, whereas proenkephalin (Penk)—encoding enkephalin—marks D2R-expressing MSNs. This pattern was subsequently confirmed in the human NAc (Hurd and Herkenham, 1995). More recent cell type–specific approaches in mice, including D1/D2 neuronal profiling (Lobo et al., 2006), translational profiling (TRAP) (Heiman et al., 2008), and single-cell transcriptomics (Saunders et al., 2018, Chen et al., 2021) consistently show that expression of Pdyn occurs almost exclusively in D1R-MSNs, with little-to-no expression in D2R-MSNs.
The present studies were designed to explore relationships between CREB and DYN expression within the NAc and stress-induced social avoidance behavior, a core feature of mood and anxiety disorders that can be studied in species ranging from mice to humans. Given convergent lines of evidence demonstrating that Pdyn in the NAc is predominantly restricted to D1R-expressing MSNs, we focused on the effects of stress on gene expression in this cell population. Using multiplex quantitative (q)RNAscope to enable simultaneous assessment of numerous transcripts (McCullough et al., 2018), we assessed expression and co-expression of Creb1 (encoding CREB), Drd1 (encoding D1Rs), and Pdyn in mice subjected to a 10-day chronic social defeat stress (CSDS) regimen and subsequently tested in open field social interaction (OFSI) tests (Donahue et al., 2014, Hisey et al., 2023). We performed this assessment in two ways: using a traditional approach where CSDS-exposed mice were segregated into stress-susceptible and resilient subgroups on the basis of social interaction behavior (Krishnan et al., 2007, Wells et al., 2017, McCullough et al., 2021), and by disaggregating the defeated subgroups to explore relationships between these markers and behavior in individual mice, leveraging variability in each endpoint. We discovered significant group differences in Drd1 and Pdyn expression using both approaches, with the disaggregated data revealing at an individual subject level strong correlations in defeated mice between levels of gene expression and social avoidance, a shared feature of MDD and PTSD.
Methods
Mice
Subjects were adult male wild-type C57BL/6 J mice obtained from Jackson Laboratory (Bar Harbor ME). To generate aggressors, virgin male and ovariectomized female Swiss Webster (CFW) mice were obtained at 8 weeks of age from Charles River (Shrewsbury, MA, USA). Mice were maintained in a temperature- and humidity-controlled vivarium under a 12-hour light/dark cycle. Food and water were available ad libitum. All housing and treatment procedures were approved by the McLean Hospital Institutional Animal Care and Use Committee following guidelines set by the National Institutes of Health.
Chronic social defeat stress (CSDS)
All mice habituated to the vivarium for one week after arrival. Male CFW mice were pair-housed with ovariectomized female CFW mice for at least one week before separation and aggressor screening. Male CFW mice with an attack latency of < 30 s for 2 consecutive days were used for social defeat. Male C57 mice were subjected to a 10-day CSDS regimen, as described previously (Donahue et al., 2014, Wells et al., 2017, McCullough et al., 2021). Each day, a C57 was placed in the home cage of an aggressive CFW male for defeat for 5 min or until 50 bites were delivered. Mice were then separated in the CFW male’s home cage by a perforated Plexiglas divider that allowed for visual and olfactory contact without further physical interaction. C57 males were placed in a new CFW male’s home cage for each subsequent defeat.
Open field social interaction (OFSI)
To identify susceptibility versus resilience to the CSDS paradigm, C57 mice were tested for social interaction in a square (45.7 × 45.7 cm) arena. The day after the tenth and final defeat session, each C57 was placed in the arena containing an empty wire cup for 150 s before removal. A nonaggressive CFW male was then placed inside the wire cup and the C57 placed back into the arena. Motion was tracked and analyzed using EthoVision (Stoelting). Social interaction ratio was calculated as the amount of time spent in the social interaction zone (2 cm around the cup) when the CFW was present divided by the time spent when the CFW was absent.
Quantitative (q)RNAscope
C57 mice were sacrificed 24 hr after OFSI, and brains were flash-frozen in isopentane on dry ice. The NAc was sectioned at 20 µm and RNAscope Multiplex Fluorescent V2 Assay (ACDBio) was conducted according to manufacturer instructions and previous studies (McCullough et al., 2018). Probes for Creb1 (Mm-CREB-C2, Cat No. 496401-C2), Drd1 (Mm-Drd1-C3, Cat No. 461901-C3) and Pdyn (Mm-Pdyn, Cat No. 318771) were hybridized to target RNA, then conjugated to Opal dyes (Akoya Biosciences) for fluorescent staining (Opal 690 for Creb1, and Opal 480 for Drd1, and Opal 570 for Pdyn).
Confocal microscopy imaging
Images of each individual hemisphere were acquired on a Leica SP8 confocal microscope using a 20X objective and a 3 × 3 tilescan at a 1.0 zoom factor. Images were z-stacks of 10 steps at 0.5 microns per step using identical settings for laser power, detector gain, and amplifier offset calibrated to the brightest section.
HALO image analysis
Images were quantified using the HALO imaging analysis software (V3.5, Indica) according to the manufacturer instructions (Halo 3.6 FISH-IF, v2.2). Probe copy intensity, used for determining the number of copies within a cluster, was set to the average intensity for cells expressing a single probe copy. DAPI and probe copy intensity, contrast threshold, signal minimum intensity, spot size, and segmentation aggressiveness were determined according to signal from positive control and noise from negative control sections.
Statistical analyses
Counts of cells expressing any or a combination of probes were normalized to total cells analyzed. Probe copies were normalized to number of cells expressing any amount of probe. A cell was considered probe-positive if it contained at least 1 copy of the probe. Data from each hemisphere per animal were averaged. Gene expression was assessed in mice classified as susceptible or resilient and compared to controls using one-way ANOVAs followed by Tukey’s multiple comparisons tests. Sub-groups were then disaggregated and relationships between social behavior and gene expression across individual mice were assessed using simple correlation (Pearson’s) analyses, followed by linear regression comparisons with F-tests to assess group (defeated versus control) differences in slopes. Finally, multiple linear regression analysis was used to assess relationships among the three genes.
Results
The day after completion of the 10-day CSDS regimen (Day 11), defeated (DEF) mice and controls (CTRLs) were assessed in OFSI tests (Fig. 1 A). As in previous studies, a social interaction ratio of time spent in the interaction zone when a novel CFW target is present versus absent was used as an index to quantify stress susceptibility (SI≥1, stress-resilient [RES]; SI≤1.0, stress-susceptible [SUS]) (Krishnan et al., 2007). When segregated into these classifications, a one-way ANOVA revealed significant group differences (F[2,12]=15.40, p = 0.0005) (Fig. 1B). Post hoc tests revealed that while there were no differences between CTRL and RES mice, SI ratios were significantly lower in SUS mice when compared to both CTRL (p = 0.0021) or RES mice (p = 0.0007). Although there were no group differences in time spent in the interaction zone when the novel CFW target was absent (F[2,12]=1.240, p = 0.3239) (Fig. 1 C), there were significant differences when it was present (F[2,12]=20.50, p = 0.0001), with SUS mice spending less time in the interaction zone than CTRL (p = 0.0042) and RES mice (p = 0.0001) (Fig. 1D). Similarly, while there were no group differences in distance traveled throughout the arena when the novel CFW target was absent (F[2,12]=2.255, p = 0.1474) (Fig. 1E), there were significant differences when it was present (F[2,12]=6.123, p = 0.0147); interestingly, distance traveled was reduced relative to CTRLs in both RES (p = 0.0238) and SUS mice (p = 0.0291) (Fig. 1 F). It is unlikely that these decreases reflect defeat-induced reductions in the ability to move, which are ruled out by the empty cup data as well as previous studies assessing CSDS effects on operant response rates (Donahue et al., 2014). Rather, these findings suggest that distance traveled per se provides limited insight on the contemporaneous sociability of the mice. These findings confirm that our CSDS regimen produces reductions in SI in a sub-population of mice (SUS) that reflect increased social avoidance behavior (Berton et al., 2006, Krishnan et al., 2007), a core feature of mood and anxiety disorders (APA, 2013), while other mice (RES) appear unaffected.
Fig. 1.
(A) Schematic of behavioral procedures involving chronic social defeat stress (CSDS) and open field social interaction (OFSI) tests. Adult male C57BL/6 J mice were defeated by adult CFW male aggressors each day on 10 consecutive days. Each defeat session was followed by 24 hr of co-housing separated by a perforated plastic divider. On Day 11, social behavior was assessed in OFSI tests. (B) When defeated mice were segregated into subgroups on the basis of their OFSI behavior, those categorized as stress-susceptible (SUS) had social interaction ratios that were significantly lower than controls (CTRLs) and those categorized as stress-resilient (RES), indicating increased social avoidance. (C) There were no group differences in time spent in the interaction zone when the wire cup was empty, but (D) SUS mice spent less time near the cup when it contained a novel CFW Target mouse than CTRL or RES mice. (E) There were no group differences in distance traveled throughout the arena when the wire cup was empty, but (F) distance traveled was lower in both RES and SUS mice compared to CTRLs when the target mouse was present. *P < 0.05, **P < 0.01, ***P < 0.001, Tukey’s post hoc tests, N’s = 5/group.
We first performed qRNAscope in situ hybridization on 20-µm sections of NAc from each mouse to assess levels of Creb1, Drd1, and Pdyn. Each hemisphere was imaged and analyzed separately, and data from each was averaged per mouse. Reliable expression of all probes was detectable (Fig. 2A-B). We then aggregated the DEF mice according to their phenotypic designations (RES, SUS), and assessed group differences in the number of cells expressing the transcripts. Overall, CSDS had no effect on any of these endpoints: there were no group differences in total the number of cells expressing DAPI (used to normalize quantification) (F[2,12]=2.531, p = 0.1210, not significant [ns]), Creb1 (F[2,12]=0.3508, p = 0.7111, ns), Drd1 (F[2,12]=1.760, p = 0.2137, ns), Pdyn (F[2,12]=0.3592, p = 0.7055; ns), or co-expressing Drd1+Pdyn (F[2,12]=0.6527, p = 0.5381, ns) (data not shown). Findings were consistent with previous reports, including ubiquitous expression of CREB (∼99% of all cells) (Carlezon et al. 2005), and that virtually all (>95%) Drd1-expressing cells co-express Pdyn (Gerfen et al., 1990). Together, these findings suggest that CSDS does not cause fundamental shifts in the number of MSNs co-expressing D1Rs and DYN.
Fig. 2.
Multiplex quantitative (q)RNAscope to assess group differences in expression of Creb1, Drd1, and Pdyn the nucleus accumbens (NAc). DAPI stain labels all cells. (A) Images from a representative stress-resilient (RES) mouse depicting each of the individual channels (DAPI=blue, Creb1=cyan, Drd1=green, Pdyn=magenta) (left) and overlay (right). (B) Images from a representative stress-susceptible (SUS) mouse, which on average had higher expression of DrD1 and Pdyn per labeled cell.
Next, we assessed group differences on the amount of transcript—reflected by the number of probe copies—per labeled (+) cell. There were no group differences in the amount of Creb1 transcript per Creb1 + cell (F[2,12]=0.2426, p = 0.7883, ns; Fig. 3A), consistent with prior evidence indicating that dynamic regulation of CREB occurs via treatment-related changes in phosphorylation rather than at the level of gene and protein expression (Carlezon et al. 2005). However, there were group differences in the amount of Drd1 per Drd1 + cell (F[2,12]=9.718, p = 0.0031 Fig. 3B), with higher expression in SUS mice compared to CTRL (p = 0.0138) and RES mice (p = 0.0036). Likewise, there were group differences in the amount of Pdyn per Pdyn+ cell (F[2,12]=4.864, p = 0.0284, Fig. 3C), with higher levels of expression in SUS compared to RES mice (p = 0.0384). Together, these findings suggest that CSDS produces neuroadaptive responses within the NAc that increase both sensitivity to the excitatory (GS-coupled) effects of DA and corresponding DYN release in SUS but not RES mice.
Fig. 3.
Quantification of Creb1, Drd1, and Pdyn levels in the NAc, as reflected by the number of probe copies per labeled cell. While there were no group differences in Creb1(A),Drd1 levels were higher in SUS mice than in RES mice or CTRL (B). Similarly, Pdyn levels were higher in SUS mice than in RES mice, which did not differ from CTRLs (C).*P < 0.05, **P < 0.01, Tukey’s post hoc tests.
Finally, we leveraged individual differences in social behavior and gene expression, enabling assessment of correlations across the entire continuum of endpoints. There were no correlations between social interaction and Creb1 copies in Creb1 + cells in DEF (SUS+RES combined) mice (Pearson r = −0.6210, p = 0.2636, ns) or CTRLs (r = 0.1801, p = 0.6185, ns) (Fig. 4A), again suggesting that stress has little effect on CREB transcript levels. There was no significant difference in slopes between the groups (F[1,11]=0.3798, p = 0.5503, ns). In contrast, there was a significant negative correlation between social behavior and Drd1 copies per Drd1 + cells (r = −0.7524, p = 0.0120), with lower social approach/higher avoidance in DEF mice correlating with higher Drd1 expression (Fig. 4B). There was no correlation in CTRL mice (r = 0.5753, p = 0.3102, ns), nor was there a group difference in slopes (F[1,11]=0.04158, p = 0.8421, ns). Similarly, there was a significant negative correlation between social behavior and Pdyn copies per Pdyn+ cell (r = −0.7822, p = 0.0075), with lower social approach/higher avoidance in DEF mice correlating with higher Pdyn (Fig. 4C). There was no correlation in CTRL mice (r = 0.6372, p = 0.2475, ns), but there was a group differences in the slopes (F[1,11]=8.630, p = 0.0135). To explore relationships among the three genes, we conducted a multiple linear regression analysis to determine if multiple variables predict one another. Considering that CREB regulates DYN expression in D1R-expressing MSNs, the most biologically-relevant comparison assesses whether Creb1 and Drd1 copies together predict levels of Pdyn expression. Indeed, Creb1, Drd1, and group (CTRL versus DEF) together significantly interact to predict Pdyn levels (F[1,13)= 7.292, p = 0.0182), and this association is a significant only in defeated mice (F(1.8)= 0.608, p = 0.0303) (not shown). Considered all together, these findings link higher social avoidance with higher expression of these genes in DEF mice, regardless of phenotypic classification as SUS or RES.
Fig. 4.
Assessment of correlations between SI behavior and gene expression when RES and SUS groups are consolidated into a single defeated (DEF) condition and compared to controls. (A) There was no correlation between SI behavior and Creb1 levels in either DEF mice or CTRLs, nor were there differences in slope. (B) There was a significant negative correlation between Drd1 levels and social behavior in DEF mice, with a higher of probe copies correlating with lower SI (i.e., higher social avoidance). The correlation was not significant in CTRLs, nor did the slopes differ. (C) Similarly, there was a significant negative correlation between Pdyn levels and social behavior in DEF mice, with a higher of probe copies correlating with lower SI. There was no correlation in CTRLs, and the slopes were significantly different between groups. *P < 0.05, **P < 0.01, Pearson’s tests; #P < 0.05, F-tests.
Discussion
Here we examined relationships between social behavior and DYN in D1R-expressing MSNs in mice exposed to CSDS, using multiplex (q)RNAscope to assess expression of Creb1, Drd1, and Pdyn within the NAc. Defeated mice were first phenotyped on the basis of their social behavior, with those classified as SUS showing lower social interaction (and thus higher social avoidance) than controls, and those classified as RES showing social interaction similar to controls. In mice categorized in this way, we saw no group differences in the number of NAc cells expressing Creb1, Drd1, Pdyn or Drd1 +Pdyn, suggesting that CSDS does not cause fundamental changes in the distribution of these transcripts. However, we identified group differences on the amount of transcript—reflected by the number of probe copies—per labeled cell. Specifically, SUS (socially-avoidant) mice had higher levels of Drd1 in Drd1 + cells and Pdyn in Pdyn+ cells, suggesting that CSDS can produces increases in D1R and DYN tone and that occurrence of such changes contributes to this phenotype. To leverage individual variability, we performed regression analyses across all mice, combining SUS+RES into a DEF condition and comparing it to controls. These analyses revealed negative correlations between social interaction behavior and expression of Drd1 and Pdyn, linking higher social avoidance with higher expression of these transcripts across a continuum of behavior and gene expression levels. No group differences or correlations were observed with Creb1, suggesting stress-induced elevations in Pdyn—a known CREB target gene (Carlezon et al., 1998, Carlezon et al., 2005)—may depend more on CREB activation (phosphorylation) than levels of the gene or protein. When considered together, these findings suggest that stress-related induction of DYN in D1R-expressing MSNs within the NAc is a biomarker of susceptibility.
Our findings are consistent with a broad literature linking increased NAc DYN and depressive behavior. Seminal work showed that elevated CREB function in the NAc produces increases in DYN expression, which leads to a variety to depressive- and anxiety-like phenotypes (Carlezon et al., 1998, Pliakas et al., 2001, Muschamp and Carlezon, 2013, Carlezon and Krystal, 2016). These effects are reproduced, at least in part, by administration of KOR agonists (which mimic DYN actions at KORs) directly into the NAc (Bals-Kubik et al., 1993, Muschamp et al., 2011). Likewise, administration of KOR agonists to humans causes signs of mood and anxiety disorders (Pfeiffer et al., 1986, Walsh et al., 2001). The depressive effects of broad elevations in CREB function within the NAc are typically attributed to elevated DYN expression in D1R-MSNs (Muschamp and Carlezon, 2013, Carlezon and Krystal, 2016), considering evidence that links this peptide and cell type in striatal regions including the NAc (Gerfen et al., 1990, Hurd and Herkenham, 1995, Lobo et al., 2006, Heiman et al., 2008, Saunders et al., 2018, Chen et al., 2021).
A wide variety of stressors—including forced swimming, footshock, and drug withdrawal—activate CREB via phosphorylation, identifying a shared molecular cascade that in humans could create psychopathology while creating interest in the use of KOR antagonists to treat depression and anxiety (Muschamp and Carlezon, 2013, Carlezon and Krystal, 2016). Interestingly, there is evidence that increased activity of NAc D1R-MSNs before stress predicts resiliency in mice (Muir et al., 2018). In the present studies, we found elevated Drd1 expression in the NAc of SUS rather than RES mice. While these findings may initially seem inconsistent, we also found elevated Pdyn in SUS mice. When considered together, these studies raise the possibility that elevated activity of D1R-MSNs is generally associated with resilience, particularly when it precedes stress exposure that produces coincident elevations in DYN. Applying this conceptualization to the present data, CSDS-induced elevations in Drd1 in SUS mice could represent a homeostatic neuroadaptation that is overshadowed by the depressive effects of elevated D1R-MSN function-related increases in DYN release. As such, elevated Pdyn creates a mixed signal in which factors associated with resilience co-occur with factors associated with susceptibility: in stressed individuals, elevations in D1 signaling that were protective before stress exposure now also produce secondary effects (e.g., enhanced inhibition of mesolimbic DA neurons via elevated DYN tone) that promote depressive behaviors including social avoidance. This mixed effect may contribute to difficulties identifying biomarkers (e.g., elevated NAc D1R expression) that can predict susceptibility to stress, particularly when an individual’s stress history is not known. Interestingly, analysis of expression among the three genes indicates that levels of Creb1 and Drd1 together predict Pdyn levels in defeated but not control mice, again suggesting that stress exposure can produce complex re-arrangements in cell function. Regardless, our studies suggest that elevated NAc DYN represents a yet-to-be explored biomarker of stress susceptibility, since its presence or absence affects the consequences of increased D1R-MSN activity (Muir et al., 2018). This hypothesis could be tested directly in humans using brain imaging.
The present proof-of principle studies have some limitations, while identifying several areas for follow-up research. Foremost, it is important to perform complementary studies in females, particularly considering that depressive illness is twice as prevalent in women as in men (Paykel, 1991, Desai and Jann, 2000) and reports of sex differences in KOR system function in rodents (Russell et al., 2014, Conway et al., 2019). It is notoriously difficult to demonstrate CSDS-induced social avoidance in female mice, although recent studies suggest that this can be mitigated by procedural changes that increase aggression during the defeat sessions (Newman et al., 2019), or by assessing other behavioral endpoints (Schuler et al., 2025). Complementary studies in female are difficult to design without reliable and well-validated behavioral endpoints to use in combination with either the traditional SUS/RES dichotomy or individual data. Additionally, the roles of other NAc cell types in DYN/KOR-related processes are currently unclear. Our analysis showed that > 95% of Drd1-labeled cells express Pdyn, meaning that approximately 5% of Drd1-labeled cells do not (or express it below our level of detection). A recent report (Bhatia et al., 2023) indicates that Drd1-expressing MSNs comprise ∼40% of all cells in the NAc; other prominent cell types include Drd2-expressing MSNs, interneurons (e.g., acetylcholine-expressing), microglia, astrocytes, and oligodendrocytes. There is strong, redundant evidence from numerous studies indicating that Pdyn expression is negligible in Drd2-expressing MSNs (Gerfen et al., 1990, Hurd and Herkenham, 1995, Lobo et al., 2006, Heiman et al., 2008, Saunders et al., 2018, Chen et al., 2021). However, there is increasing evidence that microglia express KORs and, under inflammatory conditions, DYN (Li et al., 2017, Missig et al., 2022). Presence of these markers in non-neuronal cells—where they may be regulated differently than in neurons—can make it difficult to devise circuit models, particularly without being able to identify the cell types contributing to the DYN/KOR signal. Future work is needed to comprehensively characterize DYN expression across neuronal and non-neuronal cells in the NAc under baseline conditions and in response to stress; ideally, such studies would involve multiplexing that enables simultaneous assessment across all cell types in the same tissue preparation, which is beyond the scope of the present report. Finally, it will be important to extend these types of studies to other translationally-relevant behavioral domains (e.g., anhedonia) that are also core features of stress-related illness and characterize some subtypes of depression (Dold et al. 2021). In mice, there are currently few well-validated behavioral endpoints that are conducive to segregation into the RES/SUS dichotomy, although use of disaggregated data across numerous endpoints may offer the ability to leverage individual variability to sharpen predictions and enable development of translationally-relevant biomarkers for psychiatric illness. Regardless, the present studies strengthen the link between DYN signaling in the NAc and stress-induced development and expression of depressive behaviors.
CRediT authorship contribution statement
Dominika J. Burek: Writing – review & editing, Writing – original draft, Investigation, Formal analysis, Data curation, Conceptualization. William A. Carlezon: Writing – review & editing, Writing – original draft, Supervision, Resources, Project administration, Funding acquisition, Conceptualization.
Funding
Supported by R01MH063266 (to WAC).
Declaration of Competing Interest
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Within the past 3 years, WAC has served as a consultant for AbbVie, Neumora, and Psy Therapeutics, and received sponsored research agreements from AbbVie and Delix. None of the other authors report disclosures.
References
- American Psychiatric Association . American Psychiatric Association; 2013. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, D.C. [Google Scholar]
- Bals-Kubik R., Ableitner A., Herz A., Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 1993;264:489–495. [PubMed] [Google Scholar]
- Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311:864–868. doi: 10.1126/science.1120972. [DOI] [PubMed] [Google Scholar]
- Bhatia P., Yang L., Luo J.X.J., Xu M., Renthal W. Epigenomic profiling of mouse nucleus accumbens at single-cell resolution. Mol. Cell. Neurosci. 2023;126 doi: 10.1016/j.mcn.2023.103857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Birnbaum H.G., Kessler R.C., Kelley D., Ben-Hamadi R., Joish V.N., Greenberg P.E. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress Anxiety. 2010;27:78–89. doi: 10.1002/da.20580. [DOI] [PubMed] [Google Scholar]
- Carlezon W.A., Jr, Duman R.S., Nestler E.J. The many faces of CREB. Trends Neurosci. 2005;28:436–445. doi: 10.1016/j.tins.2005.06.005. [DOI] [PubMed] [Google Scholar]
- Carlezon W.A., Jr, Krystal A.D. Kappa-opioid antagonists for psychiatric disorders: from bench to clinical trials. Depress Anxiety. 2016;33:895–906. doi: 10.1002/da.22500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carlezon W.A., Jr, Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., Nestler E.J. Regulation of cocaine reward by CREB. Science. 1998;282:2272–2275. doi: 10.1126/science.282.5397.2272. [DOI] [PubMed] [Google Scholar]
- Carroll F.I., Carlezon W.A., Jr Development of κ opioid receptor antagonists. J. Med. Chem. 2013;56:2178–2195. doi: 10.1021/jm301783x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen R., Blosser T.R., Djekidel M.N., Hao J., Bhattacherjee A., Chen W., Tuesta L.M., Zhuang X., Zhang Y. Decoding molecular and cellular heterogeneity of mouse nucleus accumbens. Nat. Neurosci. 2021;24:1757–1771. doi: 10.1038/s41593-021-00938-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conway S.M., Puttick D., Russell S., Potter D., Roitman M.F., Chartoff E.H. Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation. Neuropharmacology. 2019;146:231–241. doi: 10.1016/j.neuropharm.2018.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cuthbert B.N., Insel T.R. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013;11:126. doi: 10.1186/1741-7015-11-126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Desai H.D., Jann M.W. Major depression in women: a review of the literature. J. Am. Pharm. Assoc. 2000;40:525–537. [PubMed] [Google Scholar]
- Dold M., Bartova L., Fugger G., Kautzky A., Mitschek M.M.M., Fabbri C., Montgomery S., Zohar J., Souery D., Mendlewicz J., Serretti A., Kasper S. Melancholic features in major depression - a European multicenter study. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2021;110 doi: 10.1016/j.pnpbp.2021.110285. [DOI] [PubMed] [Google Scholar]
- Donahue R.J., Muschamp J.W., Russo S.J., Nestler E.J., Carlezon W.A., Jr Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia. Biol. Psychiatry. 2014;76:550–558. doi: 10.1016/j.biopsych.2013.12.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Jr, Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990;250:1429–1432. doi: 10.1126/science.2147780. [DOI] [PubMed] [Google Scholar]
- Greenberg P.E., Sisitsky T., Kessler R.C., Finkelstein S.N., Berndt E.R., Davidson J.R., Ballenger J.C., Fryer A.J. The economic burden of anxiety disorders in the 1990s. J. Clin. Psychiatry. 1999;60:427–435. doi: 10.4088/jcp.v60n0702. [DOI] [PubMed] [Google Scholar]
- Gros D.F., Price M., Magruder K.M., Frueh B.C. Symptom overlap in posttraumatic stress disorder and major depression. Psychiatry Res. 2012;196:267–270. doi: 10.1016/j.psychres.2011.10.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heiman M., Schaefer A., Gong S., Peterson J.D., Day M., Ramsey K.E., Suárez-Fariñas M., Schwarz C., Stephan D.A., Surmeier D.J., Greengard P., Heintz N. A translational profiling approach for the molecular characterization of CNS cell types. Cell. 2008;135:738–748. doi: 10.1016/j.cell.2008.10.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hisey E.E., Fritsch E.L., Newman E.L., Ressler K.J., Kangas B.D., Carlezon W.A., Jr Early life stress in male mice blunts responsiveness in a translationally-relevant reward task. Neuropsychopharmacology. 2023;48:1752–1759. doi: 10.1038/s41386-023-01610-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hurd Y.L., Herkenham M. The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis. Neuroscience. 1995;64:571–586. doi: 10.1016/0306-4522(94)00417-4. [DOI] [PubMed] [Google Scholar]
- Knoll A.T., Meloni E.G., Thomas J.B., Carroll F.I., Carlezon W.A., Jr Anxiolytic-like effects of kappa-opioid receptor antagonists in behavioral models of unlearned and learned fear in rats. J. Pharmacol. Exp. Ther. 2007;323:838–845. doi: 10.1124/jpet.107.127415. [DOI] [PubMed] [Google Scholar]
- Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., Ghose S., Reister R., Tannous P., Green T.A., Neve R.L., Chakravarty S., Kumar A., Eisch A.J., Self D.W., Lee F.S., Tamminga C.A., Cooper D.C., Gershenfeld H.K., Nestler E.J. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell. 2007;131:391–404. doi: 10.1016/j.cell.2007.09.018. [DOI] [PubMed] [Google Scholar]
- Li T.F., Wu H.Y., Wang Y.R., Li X.Y., Wang Y.X. Molecular signaling underlying bulleyaconitine A (BAA)-induced microglial expression of prodynorphin. Sci. Rep. 2017;7 doi: 10.1038/srep45056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lobo M.K., Karsten S.L., Gray M., Geschwind D.H., Yang X.W. FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains. Nat. Neurosci. 2006;9:443–452. doi: 10.1038/nn1654. [DOI] [PubMed] [Google Scholar]
- McCullough K.M., Missig G., Robble M.A., Foilb A.R., Wells A.M., Hartmann J., Anderson K.J., Neve R.L., Nestler E.J., Ressler K.J., Carlezon W.A., Jr Nucleus accumbens medium spiny neuron subtypes differentially regulate stress-associated alterations in sleep architecture. Biol. Psychiatry. 2021;89:1138–1149. doi: 10.1016/j.biopsych.2020.12.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCullough K.M., Morrison F.G., Hartmann J., Carlezon W.A., Jr, Ressler K.J. Quantified co-expression analysis of central amygdala sub-populations. ENEURO. 2018;5(1) doi: 10.1523/ENEURO.0010-18.2018. 0010-18.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Missig G., Fritsch E.L., Mehta N., Damon M.E., Jarrell E.M., Bartlett A.A., Carroll F.I., Carlezon W.A., Jr Blockade of kappa-opioid receptors amplifies microglia-mediated inflammatory responses. Pharmacol. Biochem. Behav. 2022;212 doi: 10.1016/j.pbb.2021.173301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muir J., Lorsch Z.S., Ramakrishnan C., Deisseroth K., Nestler E.J., Calipari E.S., Bagot R.C. Vivo fiber photometry reveals signature of future stress susceptibility in nucleus accumbens. Neuropsychopharmacology. 2018;43:255–263. doi: 10.1038/npp.2017.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muschamp J.W., Carlezon W.A., Jr Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation. Cold Spring Harb. Perspect. Med. 2013;3 doi: 10.1101/cshperspect.a012005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muschamp J.W., Van’t Veer A.V., Parsegian A., Gallo M.S., Chen M., Neve R.L., Meloni E.G., Carlezon W.A., Jr Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats. J. Neurosci. 2011;31:3095–3103. doi: 10.1523/JNEUROSCI.5973-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nemeth C., Paine T.A., Rittiner J., Béguin C., Carroll F.I., Roth B.L., Cohen B.M., Carlezon W.A., Jr Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention behavior in rats. Psychopharmacology. 2010;210:263–274. doi: 10.1007/s00213-010-1834-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newman E.L., Covington H.E., 3rd, Suh J., Bicakci M.B., Ressler K.J., DeBold J.F., Miczek K.A. Fighting females: neural and behavioral consequences of social defeat stress in female mice. Biol. Psychiatry. 2019;86:657–668. doi: 10.1016/j.biopsych.2019.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nestler E.J., Carlezon W.A., Jr The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry. 2006;59:1151–1159. doi: 10.1016/j.biopsych.2005.09.018. [DOI] [PubMed] [Google Scholar]
- Paykel E.S. Depression in women. Br. J. Psychiatry Suppl. 1991:22–29. [PubMed] [Google Scholar]
- Pfeiffer A., Brantl V., Herz A., Emrich H.M. Psychotomimesis mediated by kappa opiate receptors. Science. 1986;233:774–776. doi: 10.1126/science.3016896. [DOI] [PubMed] [Google Scholar]
- Pliakas A.M., Carlson R., Neve R.L., Konradi C., Nestler E.J., Carlezon W.A., Jr Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element binding protein expression in nucleus accumbens. J. Neurosci. 2001;21:7397–7403. doi: 10.1523/JNEUROSCI.21-18-07397.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ressler K.J., Berretta S., Bolshakov V.Y., Rosso I.M., Meloni E.G., Rauch S.L., Carlezon W.A., Jr Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits. Nat. Rev. Neurol. 2022;18(5):273–288. doi: 10.1038/s41582-022-00635-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Russell S.E., Rachlin A.B., Smith K.L., Muschamp J., Berry L., Zhao Z., Chartoff E.H. Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats. Biol. Psychiatry. 2014;76:213–222. doi: 10.1016/j.biopsych.2013.07.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saunders A., Macosko E.Z., Wysoker A., Goldman M., Krienen F.M., de Rivera H., Bien E., Baum M., Bortolin L., Wang S., Goeva A., Nemesh J., Kamitaki N., Brumbaugh S., Kulp D., McCarroll S.A. Molecular diversity and specializations among the cells of the adult mouse brain. Cell. 2018;174:1015–1030. doi: 10.1016/j.cell.2018.07.028. e16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schuler H., Eid R.S., Wu S., Tse Y.C., Cvetkovska V., Lopez J., Quinn R., Zhou D., Meccia J., Dion-Albert L., Bennett S.N., Newman E.L., Trainor B.C., Peña C.J., Menard C., Bagot R.C. Data-driven analysis identifies novel modulation of social behavior in female mice witnessing chronic social defeat stress. Biol. Psychiatry. 2025;98:416–426. doi: 10.1016/j.biopsych.2024.11.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Svingos A.L., Colago E.E., Pickel V.M. Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. J. Neurosci. 1999;19:1804–1813. doi: 10.1523/JNEUROSCI.19-05-01804.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Svingos A.L., Chavkin C., Colago E.E., Pickel V.M. Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles. Synapse. 2001;42:185–192. doi: 10.1002/syn.10005. [DOI] [PubMed] [Google Scholar]
- Walsh S.L., Geter-Douglas B., Strain E.C., Bigelow G.E. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J. Pharmacol. Exp. Ther. 2001;299:147–158. [PubMed] [Google Scholar]
- Wells A.M., Ridener E., Bourbonais C.A., Kim W., Pantazopoulos H., Carroll F.I., Kim K.S., Cohen B.M., Carlezon W.A., Jr Effects of chronic social defeat stress on sleep and circadian rhythms are mitigated by kappa-opioid receptor antagonism. J. Neurosci. 2017;37:7656–7668. doi: 10.1523/JNEUROSCI.0885-17.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]




